Early antithrombotic therapy for another highly lethal viral pneumonia pandemic

被引：0

作者：

Wu, Xiaoming ^{[1
]}

Xiang, Mengqi ^{[1
]}

Jing, Haijiao ^{[1
]}

Liu, Langjiao ^{[1
]}

Wang, Chunli ^{[1
]}

Novakovic, Valerie A. ^{[2
]}

Shi, Jialan ^{[1
,2
,3
,4
]}

机构：

[1] Harbin Med Univ, Hosp 1, Dept Hematol, Harbin, Peoples R China

[2] Harvard Med Sch, Dept Res, VA Boston Healthcare Syst, Boston, MA USA

[3] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA

[4] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2023年 / 29卷 / 03期

关键词：

Antithrombotic therapy; COVID-19; Mortality; Phosphatidylserine; Viral pneumonia; pandemic; ACUTE RESPIRATORY SYNDROME; CRITICALLY-ILL PATIENTS; THROMBOTIC EVENTS; SYNDROME SARS; INFLUENZA; INFECTION; COVID-19; DISEASE; COAGULATION; ACTIVATION;

D O I：

10.1016/j.cmi.2022.11.008

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：284 / 287

页数：4

共 55 条

[1] Al Raizah A, 2021, BLOOD, V138
[2] Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study
Arabi, Yaseen M.
Al-Omari, Awad
Mandourah, Yasser
Al-Hameed, Fahad
Sindi, Anees A.
Alraddadi, Basem
Shalhoub, Sarah
Almotairi, Abdullah
Al Khatib, Kasim
Abdulmomen, Ahmed
Qushmaq, Ismael
Mady, Ahmed
Solaiman, Othman
Al-Aithan, Abdulsalam M.
Al-Raddadi, Rajaa
Ragab, Ahmed
Al Mekhlafi, Ghaleb. A.
Al Harthy, Abdulrahman
Kharaba, Ayman
Al Ahmadi, Mashael
Sadat, Musharaf
Al Mutairi, Hanan
Al Qasim, Eman
Jose, Jesna
Nasim, Maliha
Al-Dawood, Abdulaziz
Merson, Laura
Fowler, Robert
Hayden, Frederick G.
Balkhy, Hanan H.
[J]. CRITICAL CARE MEDICINE, 2017, 45 (10) : 1683 - 1695
[3] Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection
Arabi, Yaseen M.
Arifi, Ahmed A.
Balkhy, Hanan H.
Najm, Hani
Aldawood, Abdulaziz S.
Ghabashi, Alaa
Hawa, Hassan
Alothman, Adel
Khaldi, Abdulaziz
Al Raiy, Basel
[J]. ANNALS OF INTERNAL MEDICINE, 2014, 160 (06) : 389 - +
[4] Endothelial activation and dysfunction in the pathogenesis of influenza A virus infection
Armstrong, Susan M.
Darwish, Ilyse
Lee, Warren L.
[J]. VIRULENCE, 2013, 4 (06) : 537 - 542
[5] Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study
Assiri, Abdullah
Al-Tawfiq, Jaffar A.
Al-Rabeeah, Abdullah A.
Al-Rabiah, Fahad A.
Al-Hajjar, Sami
Al-Barrak, Ali
Flemban, Hesham
Al-Nassir, Wafa N.
Balkhy, Hanan H.
Al-Hakeem, Rafat F.
Makhdoom, Hatem Q.
Zumla, Alimuddin I.
Memish, Ziad A.
[J]. LANCET INFECTIOUS DISEASES, 2013, 13 (09) : 752 - 761
[6] Thromboembolic events in patients with severe pandemic influenza A/H1N1
Avnon, Lone Solling
Munteanu, Daniela
Smoliakov, Alexander
Jotkowitz, Alan
Barski, Leonid
[J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2015, 26 (08) : 596 - 598
[7] Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449
[8] Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
Bonaventura, Aldo
Vecchie, Alessandra
Dagna, Lorenzo
Martinod, Kimberly
Dixon, Dave L.
Van Tassell, Benjamin W.
Dentali, Francesco
Montecucco, Fabrizio
Massberg, Steffen
Levi, Marcel
Abbate, Antonio
[J]. NATURE REVIEWS IMMUNOLOGY, 2021, 21 (05) : 319 - 329
[9] Pandemic H1N1 Influenza Infection and Vascular Thrombosis
Bunce, Paul E.
High, Sasha M.
Nadjafi, Maral
Stanley, Katherine
Liles, W. Conrad
Christian, Michael D.
[J]. CLINICAL INFECTIOUS DISEASES, 2011, 52 (02) : E14 - E17
[10] Thrombocytopenia as a mortality risk factor in acute respiratory failure in H1N1 influenza
Carlos Lopez-Delgado, Juan
Rovira, Assumpta
Esteve, Francisco
Rico, Nicolas
Manez Mendiluce, Rafael
Ballus Noguera, Josep
Berrade, Julian
[J]. SWISS MEDICAL WEEKLY, 2013, 143

← 1 2 3 4 5 6 →